NeuroDerm - Articles and news items

FDA lifts clinical hold on ND0612H and ND0612L for the treatment of Parkinson’s disease

Industry news / 8 May 2015 /

The FDA has lifted the clinical hold on clinical studies of ND0612H and ND0612L, NeuroDerm’s product candidates for the treatment of Parkinson’s disease…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+